Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$13.59 n/a | n/a%
11/26/14 - 03:59 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
CHRSSector Avg.S&P 500
n/a025.98
Price Performance History (% change):
3 Mo1 Yr3 Yr
000
GROWTH12 Mo3 YrCAGR
Revenue00
Net Income00
EPS0n/a
Earnings for CHRS:
EBITDA-35.00
REVENUE2.75M
Average Earnings Estimates
Qtr (07/12) Qtr (10/12) FY (01/13) FY (01/14)
Average Estimate $0.06 $-0.03 $0.27 $0.38
Number of Analysts 3 3 4 2
High Estimate $0.07 $-0.01 $0.35 $0.40
Low Estimate $0.04 $-0.06 $0.22 $0.36
Prior Year $-0.01 $-0.08 $0.03 $0.27
Growth Rate (Year over Year) 700.00% 62.50% 808.33% 39.45%

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter